The largest database of trusted experimental protocols

14 protocols using cd62l fitc

1

Multiparameter Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse spleens were homogenized, and single-cell suspensions were prepared and counted after lysis with RBC lysis buffer (BioLegend). For macrophage staining, 1 × 106 cells were incubated with FITC-F4/80 (Biolegend) and APC-Ly6c (Biolegend) antibodies at room temperature for 30 min. The cells were rinsed with 1 ml PBS and resuspended with 200 μl PBS for detection. For the detection of Tcm (central memory T cell) and Tem (effector memory T cell), 1 × 106 cells were incubated with FITC-CD62L (Biolegend), PE-CD44 (Biolegend), Percp-cy5.5-CD4 (Biolegend), and APC-CD8 (Biolegend) antibodies for 30 min. The cells were then subjected to 1 ml PBS washing, followed by suspending with 200 μl PBS for cytometry detection. For intracellular staining, 2 × 106 cells were stimulated with PMA plus ionomycin (Invitrogen) for 5 hr. After incubation with FITC-CD4 (Biolegend) and PE-CD8 (Biolegend) antibodies at room temperature for 30 min, the cells were then incubated with Fix/Perm according to kit instructions and APC-IFN-γ (Biolegend) antibodies for 30 min. Then the cells were rinsed with 1 ml PBS and resuspended with 200 μl PBS for detection.
+ Open protocol
+ Expand
2

Multiparameter Flow Cytometry Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
The surface markers included FITC‐CD3 (MA1‐7640, eBioscience, San Diego, CA, USA), APC‐Cy7‐CD4 (100413, Biolegend, San Diego, CA, USA), APC‐CD4 (100411, Biolegend), PerCP‐CD8 (100,731, Biolegend), PE‐Cy7‐CD8 (100721, Biolegend), PE‐Foxp3 (12‐5773‐82, eBioscience), APC‐Helios (17‐9883‐42, eBioscience), PerCP‐CD44 (103035, Biolegend), FITC‐CD62L (104405, Biolegend), FITC‐lin (22‐7770‐72, eBioscience), PerCP‐CD34 (50‐0341‐82, eBioscience), APC‐Sca‐1 (17‐5981‐82, eBioscience), PE‐Sca‐1 (12‐5981‐82, eBioscience), APC‐c‐kit (17‐1171‐82, eBioscience), PE‐c‐kit (12‐1171‐82, eBioscience), PE‐B220 (12‐0452‐82, eBioscience), FITC‐IgM (11‐5790‐81, eBioscience), PE‐Cy7‐CD19 (12‐0193‐82, eBioscience), APC‐CD19 (17‐0193‐82, eBioscience), PE‐Cy7‐CD16/32 (25‐0161‐82, eBioscience), PE‐Cy7‐CD45 (25‐0451‐82, eBioscience), PerCP‐5.5‐CD45.2 (45‐0454‐82, eBioscience), and APC‐Cy7‐CD45.1 (17‐0453‐82, eBioscience) obtained from Invitrogen. Intracellular staining with PE‐Foxp3 (72‐5775‐40, eBioscience) was performed with Foxp3 staining kits (Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand
3

Tumor Immune Cell Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tumors were processed for flow cytometry into single cells using mechanical and enzymatic digestion (enzyme mixture—collagenase, DNAse, and hyaluronidase). Red blood cells were lysed as described above and viable tumor cells counted. The following antibodies were used to stain immune cell populations: Ghost violet 510 Live/Dead, Pacific Blue CD45, PE-594 CD3, PE/Cy7 CD8, APC/Cy7 CD4, BV605 PD-1, APC Tim3, FITC CD62L, BV711 CD44 (BioLegend).
Samples were run on an LSR Fortessa machine. Single color compensation controls were performed using compensation beads (Thermo Fisher Scientific, Waltham, MA, USA) to correct for overlap in signal among antibodies. Spleen samples were used to set a gating strategy for CD3+/CD4+ and CD3+/CD8+ T cells. FlowJo software (version 10) was used to perform all downstream analyses on subpopulations.
+ Open protocol
+ Expand
4

Generating and Staining pMHC Multimers

Check if the same lab product or an alternative is used in the 5 most similar protocols
pMHC monomers were generated as previously described66 (link). All pMHC-multimer reagents were generated by 45 min incubation of 4 μg biotinylated pMHC monomer with 1 μg streptavidin-BV421 (Biolegend, reference #405225) or Streptavidin-APC (eBioscience, reference #17-4317-82) in a total volume of 100 μl FACS buffer for staining of up to 1x107 cells. pMHC-multimer staining was performed separately from surface antibody staining for 45 min on ice. Surface antibody staining was performed for 25 min on ice subsequent to pMHC-multimer staining. Depending on the respective experiments, a subset of the following antibodies were used: anti-human TCR α/β FITC (BioLegend, reference #306706), CD3 PC7 (Beckman Coulter, reference #737657), CD8 PE (Invitrogen, reference #MHCD0804), anti-murine TCR β-chain APC (BioLegend, reference #109212), anti-murine TCR β-chain APC/Fire750 (BioLegend, reference #109246), CD62L FITC (Biolegend, reference #304804), CD45-RO PC7 (BioLegend, reference #304230), Lag3 FITC (Biolegend, reference #369308) and PD-1 APC (Invitrogen, reference #17-2799-42). Live/dead discrimination was performed with propidium iodide (LifeTechnologies, reference #P1304MP).
+ Open protocol
+ Expand
5

Polychromatic Flow Cytometry for Treg and Th Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Regulatory T cells (Treg) were defined as CD4+CD25+CD127low/- cells. Other CD4+T subsets were identified by differential expression of CCR4, CXCR3, and CCR6 as previously reported (7 (link), 9 (link)): CXCR3+CCR4CCR6− (Th1), CXCR3CCR4+CCR6 (Th2), CXCR3CCR4+CCR6+(Th17), and CXCR3+CCR4CCR6+ (Th1Th17) (Figure 1). In addition, Th17 cells were defined as the summation of CXCR3CCR4+CCR6+ (Th17) and CXCR3+CCR4CCR6+(Th1Th17).
The fluorochrome-conjugated antibodies used for polychromatic flow cytometry analysis were CD3-BV510 (Biolegend, USA, catalog no. 317332), CD4-APC-Cy7 (Biolegend, USA, catalog no. 317418), CCR4-APC (Biolegend, USA, catalog no. 359404), CXCR3-PE (Biolegend, USA, catalog no. 353706), CCR6-PE-Cy7 (Biolegend, USA, catalog no. 353418), CD25-BV421 (Biolegend, USA, catalog no. 302630), CD127-FITC (Biolegend, USA, catalog no. 351312), PE-Cy7-CCR7 (Biolegend, USA, catalog no. 353226) and CD62L-FITC (Biolegend, USA, catalog no. 304804). A viability dye, 7-AAD (Becton Dickinson, USA, catalog no. 559925), was used to exclude dead cells. Isotype antibodies were also used as negative controls for every detection to set proper gating for the receptor expression. Cells were analyzed by fluorescence-activated cell sorting (FACS), using the BD LSRII cytometer and FlowJo software.
+ Open protocol
+ Expand
6

Flow Cytometry Analysis of Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed using a BD Biosciences LSRFortessa. For direct ex vivo staining of lymphocytes, 1×106 to 2×106 cells were resuspended in 100 mL of FACS buffer (PBS þ 1% Fetalclone III), and Fc receptors were blocked for 10 to 15 minutes at 4 C with 1 µg/sample of 2.4G2 mAb (CD16 and CD32 blockade) and 1 µg/sample of mouse IgG (ThermoPierce). Cells were fluorescently labeled with antibodies for 30 minutes at 4 C, washed, and resuspended in fixation buffer (2% formaldehyde in PBS), or intracellularly stained according to the manufacturer's protocol (eBiosciences). The following fluorescently labeled anti- mouse mAbs were used for flow cytometry: IFNγ -FITC, IFNγ-PE, CD44-PerCP-Cy5.5, CD4-APC, CD8a-APC (BioLegend); CD62L- FITC, FoxP3-PE, TNFα-PerCP-eFluor 710, CD45-eFluor 450, CD4-eFluor450, CD62L-eFluor 450, CD4-APC-eFluor 780, and CD8a-APC-eFluor 780 (eBioscience); active caspase-3-PE (BD Biosciences). Flow cytometry data were analyzed with FCS Express 4 (De Novo Software).
+ Open protocol
+ Expand
7

Comprehensive Treg Phenotyping by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies used for flow cytometry were as follows: CD4-Pacific Blue, CD25-PE, CD25-APC, CD127-FITC, Foxp3-PE, CD38-PE-Cy7, AnnexinV-PE, PD1-APC, CD8-FITC, CTLA4-PE-Cy7, CD44-FITC, CD62L-FITC, ICOS-FITC, GITR-PE, OX40-FITC, CD138-FITC, PD-L1-PE, and their isotype-matched mAbs (all from Biolegend). Intracellular staining of Foxp3, CTLA4, GITR, and OX40 were performed after fixation and permeabilization using cytofix/cytoperm kit (BD Biosciences), according to manufacturer’s protocol. Tregs were gated as CD4+CD25highFoxp3+ cells in CD4+ population and then sequential markers were assayed on Tregs, whereas CD4+CD25− cells were identified as Tcons. The remaining CD4+CD25low/intermediate subset was excluded in the current study because of their limited immunosuppressive activity compared with CD25high population (34 (link)). To avoid the effect of permeabilization when apoptosis assay was performed, CD4+CD25highCD127low/− cells were identified as Tregs (35 (link)). All flow cytometry was performed by BD FACS CantoII, and analyzed on FlowJo software version 10 (Treestar).
+ Open protocol
+ Expand
8

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were extracted from lymph nodes, spleen, or colon tissue digested by collagenase. Isolated cells were stained with following antibodies: CD8-PE-CY7 (Thermo Scientific), CD4-APC-Fire™ 750 (BioLegend), IFN-γ-FITC (BioLegend), IL-17-APC (BioLegend), FOXP3-PE (BioLegend), CD19-PE (BioLegend), NK1.1-FITC (BioLegend), CD11B-APC (BioLegend), Gr-1-FITC (BioLegend), F4/80-PE (BioLegend), CD11C-APC-CY7 (BioLegend), MHC-II-PE/Dazzle™ 594 (BioLegend), CD8-APC (BioLegend), Ki67-PerCP-CY5.5 (BioLegend), Annexin V-FITC (BioLegend), CD103-PE (BioLegend), CD69-PE-CY7 (BioLegend), CD44-PE-CY7 (BioLegend), CD62L-FITC (BioLegend), CD107-FITC (BioLegend), IFN-γ-APC (BioLegend), CD107-PE (BioLegend), IFN-γ-PE (BioLegend), CD3-FITC (BioLegend), CD3-APC/Fire™ 750 (BioLegend), CD8-APC (BioLegend), IFN-γ-PE-CY7 (BioLegend), CD69-APC/Fire™ 750 (BioLegend), Tetramer-SIINFEKL-PE (MBL), p-JNK-PE (Cell Signaling Technology), p-IRAK4-Alexa Fluor 488 (Cell Signaling Technology). Intracellular staining was carried out using the Cytofix/Cytoperm kit (BD Pharmingen) following a 4 h restimulation by PMA/ionomycin (Sigma) in the presence of GolgiPlug (BD Pharmingen). Flow cytometric data acquisition was performed on a NovoExpress flow cytometer and analyzed with NovoExpress software (ACEA Biosciences).
+ Open protocol
+ Expand
9

Profiling CMV- and IAV-specific CD8+ T cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The procedure of flow cytometric analysis of CMV- and IAV-specific CD8+ T cells prior to and post in vitro stimulation was described [40 (link)]. Briefly, freshly PMBCs were stained with fluorescently labeled dextramers or tetramers specific to CMV-pp65 (NLVPMVATV) and IAV-M1 (GILGFVFTL) (Immudex, Copenhagen, Denmark and NIAID tetramer core) first at room temperature for 20 min; followed by staining of cell surface markers including antibody against CD3, CD8, CD62L, CD45RA, CD95, CD27, CD28 CD70, CD127, and CD69 at 4°C for 30 min. Cells were washed again with FACS buffer (Hanks solution with 0.3% Sodium Azide), and then fixed immediately with 3% formaldehyde and 1% FBS in FACS buffer. Fixed cells were further stained with intracellular markers (perforin and granzyme B) at 4°C for 30 min. Stained cells were collected by BD_Symphony and were analyzed using FlowJo version 7.6.5 software.
Antibodies (CD3-BV570, CD62L-FITC, CD62L-PE-Cy7, CD45RA-PE-Cy7, CD45RA-APC, CD95-PE-Cy5, CD27-PE, CD28-BV785, CD28-PerCP-Cy5.5, CD70-PE, CD127--BV711, CD69-BV650, and granzyme B) were purchased from Biolegend, and antibodies against CD8-BUV496, CD27-BUV395, and perforin-PE-CF594 were purchased from BD.
+ Open protocol
+ Expand
10

Detailed Peptide-Stimulated T Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells isolated from spleen, lungs or peripheral blood were cultured with 2 µg/ml of two immunodominant peptides (Pepscan, Lelystad, The Netherlands), [SSTHEANTMAMMARDT] and [AGYAGTLQSLGAEIAV] of the TB10.4 protein, previously demonstrated to stimulate both CD4+ & CD8+ T cell responses (Kaveh & Hogarth, unpublished); 1 µg/ml anti-CD28 (BD Biosciences) and 10 µg/ml Brefeldin A (Sigma) for 16 h at 37 °C/5% CO2. Cells were washed at 300 g for 5 min and surface stained with combinations of CD62L-FITC, CD27-PerCP-Cy5.5, CD8-AF700, CD44-BV421, CD127-PE-Cy7, CD69-FITC, CCR7-BV421, live/dead-Zombie Aqua (all BioLegend) and CD4-APC-H7 (BD Biosciences). Cells were then washed, treated with BD Biosciences Cytofix/Cytoperm as per manufacturer’s instructions and stained intracellularly with combinations of IFN-γ-PE-Cy7, IL-2-APC (both eBioscience), IFN-γ-BV605 and TNF-α-BV605 (both BioLegend). Cells were washed again and analysed using an LSRFortessa™ analyser utilising a 532 nm laser for PE and PE-conjugate excitation with FACSDiva™ software (BD Biosciences). Final analysis was performed using FlowJo® software (Tree Star Inc.) on a minimum of 100,000 live lymphocytes (50,000 for peripheral blood).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!